Johns Hopkins Medicine study finds targeting the Aplp1 and Lag3 interaction could slow the progression of Parkinson’s and potentially treat other neurodegenerative diseases. Johns Hopkins...
from SciTechDaily https://ift.tt/m9W1tMs
Johns Hopkins Researchers Identify New Biological Target for Stopping Parkinson’s Disease Progression
July 05, 2024
0
Tags
